62
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14045 |
Leukotriene B4
LTB4,5(S),12(R)-DiHETE |
Others | Others |
Leukotriene B4 is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | |||
T37619 |
Leukotriene B4 Ethanolamide
|
||
The effects of Leukotriene B4 (LTB4) are mediated by two known receptors, BLT1 and BLT2. LTB4 is a high affinity ligand for BLT1, and many of its pro-inflammatory effects are believed to be transduced through this receptor. The BLT2 is more enigmatic, in that LTB4 is not a high-affinity ligand, nor is it clear that BLT2 activation promotes inflammation. LTB4 ethanolamide (LTB4-EA) is a theoretical 5-LO metabolite of arachidonoyl ethanolamide (AEA). In CHO cells transfected with human BLTR1, LTB4... | |||
T37618 |
Leukotriene B4 dimethyl amide
Leukotriene B4 dimethyl amide |
||
LTB4 dimethyl amide is a moderate inhibitor of LTB4-induced degranulation of human neutrophils (Ki = 130 nM) and lysozyme release from rat PMNL. LTB4 dimethyl amide appears to be an antagonist of the LTB4 receptor on guinea pig lung membranes. | |||
T37256 |
12-oxo Leukotriene B4
12-oxo Leukotriene B4 |
||
Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-LO pathway. It promotes a number of leukocyte functions including aggregation, stimulation of ion fluxes, enhancement of lysosomal enzyme release, superoxide anion production, chemotaxis, and chemokinesis. 12-oxo LTB4 is an initial metabolite of LTB4 formed via the LTB4 12-hydroxydehydrogenase pathway. It is rapidly converted to 10,11-dihydro-12-oxo-LTB4, followed by reduction of the 12-oxo group to give ... | |||
T38087 |
20-hydroxy Leukotriene B4
20-hydroxy Leukotriene B4 |
||
20-hydroxy LTB4 is a metabolite of LTB4 in human neutrophils. In human leukocytes, LTB4 is inactivated by the enzyme LTB4 20-hydroxylase. 20-hydroxy LTB4 is not only much less active (~5%) compared to LTB4 in causing degranulation of PMNL, but actually inhibits LTB4-induced degranulation of human neutrophils (Ki = 13.3 nM). However, 20-hydroxy LTB4 is as active as LTB4 in contracting parenchymal strips from guinea pig lung. 20-hydroxy LTB4 retains considerable ligand binding affinity at the BLT2... | |||
T37970 |
12-epi Leukotriene B4
12-epi Leukotriene B4 |
||
Leukotriene B4 (LTB4) compounds are produced by both enzymatic and non-enzymatic processes. The products of enzymatic origin, via Leukotriene A4 (LTA4) hydrolase, are stereospecifically 12(R). Non-enzymatic hydrolysis products are 50:50 mixtures at C-12, but are almost exclusively trans at C-6. Thus, the non-enzymatic hydrolysis product of LTA4 is 6-trans-12-epi LTB4. 12-epi LTB4 is an isomer which would not be expected to occur in either non-enzymatic hydrolysis products, or in the enzymatic pr... | |||
T37260 |
14,15-dehydro Leukotriene B4
14,15-dehydro Leukotriene B4 |
||
Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-lipoxygenase pathway. It promotes a number of leukocyte functions including aggregation, stimulation of ion fluxes, enhancement of lysosomal enzyme release, superoxide anion production, chemotaxis, and chemokinesis. At least two LTB4 receptors, termed BLT1 and BLT2, have been identified. 14,15-dehydro LTB4 is a LTB4 receptor antagonist that has a higher binding affinity for BLT1, demonstrating a Ki value ... | |||
T73793 |
20-Carboxy-Leukotriene B4
|
||
20-Carboxy-Leukotriene B4 (20-COOH LTB4) 是 Leukotriene B4 (LTB4) 的代谢物。20-Carboxy-Leukotriene B4 以高亲和力与 BLT1 受体结合。20-Carboxy-Leukotriene B4 抑制 LTB4 介导的中性粒细胞反应,迁移、脱粒、白三烯生物合成。 | |||
T72144 |
6-trans-12-epi-Leukotriene B4
|
||
6-trans-12-epi-Leukotriene B4 是一种花生四烯酸代谢物,是一种有效的抗炎剂。 | |||
T15002 |
CP-105696
Pfizer 105696 |
LTR | Immunology/Inflammation |
CP-105696 是一种具有强效性和选择性白三烯 B4 (LTB4) 受体拮抗剂,可用于研究异体移植物排斥反应。 | |||
T77638 |
BIRM 271
|
Phospholipase; LTR | Immunology/Inflammation; Metabolism |
BIRM 271 是一种新型花生四烯酸释放抑制剂,可阻断白三烯B4和人中性粒细胞中的血小板活化因子生物合成。BIRM 271 和 BIRM 270 属于对映异构体,对白三烯B4 的产生有抑制作用,IC50 为40 nM。 | |||
T3715 |
Acebilustat
阿西鲁司特,CTX-4430 |
Aminopeptidase; LTR | Immunology/Inflammation; Metabolism |
Acebilustat (CTX-4430) 是一种具有口服活性的白三烯 A4 水解酶抑制剂,可用于炎症研究。 | |||
T17191 |
Bunaprolast
U66858 |
Lipoxygenase; LTR | Immunology/Inflammation; Metabolism |
Bunaprolast (U66858) 是一种新型有效的白三烯 B4 (LTB4) 抑制剂。Bunaprolast 具有氧化降解活性,对脂氧合酶 (lipoxygenase)和 TXB2 释放具有抑制作用。 | |||
T22946 |
LY255283
LY 255283 |
Leukotriene Receptor | GPCR/G Protein |
LY255283 是白三烯 B4 (LTB4) 受体的特异性拮抗剂,抑制人外周血多形核白细胞和由钙离子载体 A23187 激活的单核细胞中 LTB(4) 的产生。 | |||
T68119 |
Ontazolast
BIRM-270 |
LTR | Immunology/Inflammation |
Ontazolast 是一种小分子白三烯B4受体(LTB4R)拮抗剂,可用于治疗免疫系统疾病和呼吸系统疾病。Ontazolast 是治疗哮喘的候选化合物。 | |||
T68108L |
Moxilubant HCl
Moxilubant hcl(146978-48-5 Free base) |
LTR | Immunology/Inflammation |
Moxilubant HCl 是一种小分子白三烯 B4 受体 1(LTB4R)拮抗剂,可用于治疗免疫系统疾病、皮肤和肌肉骨骼疾病,可用于研究银屑病和类风湿关节炎。 | |||
T28974 |
Ticolubant
|
Calcium Channel; LTR | Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism |
Ticolubant 是一种具有口服活性的白三烯 B4 拮抗剂,对人类中性粒细胞 LTB4 受体具有很高的亲和力(Ki = 0.78 nM),能阻断 LTB4 诱导的 Ca2+ 迁移,IC50 为 6.6±1.5 nM,并在小鼠皮肤炎症模型中显示出局部抗炎活性。 | |||
T22358 |
Etalocib
LY293111,VML295 |
Apoptosis; Leukotriene Receptor; LTR | Apoptosis; GPCR/G Protein; Immunology/Inflammation |
Etalocib (LY293111) 是一种具有口服活性的白三烯(LTB4)受体的拮抗剂,抑制 [3H]LTB4结合的 Ki 值为 25 nM。它还可诱导凋亡。它抑制 LTB4诱导的钙动员,lC50值为 20 nM。 | |||
T9878 |
Croconazole
|
Lipoxygenase; LTR | Immunology/Inflammation; Metabolism |
Croconazole 对中性粒细胞的 5-脂氧合酶 (5-LOX) 表现出剂量依赖性抑制活性。Croconazole 是一种抗真菌剂。Croconazole 对合成白三烯 B4 (LTB4) 和 5-羟基二十碳四烯酸 (5-HETE) 的 IC50 分别为 7.8 ± 1.7 和 7.6 ± 0.3 μM。 | |||
T28667 |
SB 201146
SB-201146,SB201146 |
||
SB 201146 is a leukotriene B4 antagonist with high affinity. | |||
T28527 |
RG 14893
|
||
RG 14893 is a antagonist of high-affinity leukotriene B4 receptor. | |||
T27913 |
LY 292728
LY292728,LY-292728 |
||
LY 292728 is a highly potent antagonist of leukotriene B4 receptor. | |||
T27896 |
LY 213024
LY-213024,LY213024 |
||
LY 213024 is an antagonist of leukotriene B4 receptor. | |||
T15801 | LY210073 | Others | Others |
LY210073 is an antagonist of the Leukotriene B4 (LTB4) receptor (IC50: 6.2 nM). | |||
T26809 |
BIIL 260
BIIL260,BIIL-260 |
||
BIIL 260 is a leukotriene B4 (BLT1) receptor antagonist with anti-inflammatory activity. | |||
T70477 |
SC 53228
|
||
SC 53228 is a specific leukotriene B4 receptor antagonist. | |||
T68418 | Furodysinin lactone | ||
Furodysinin lactone is an agonist of human leukotriene B4 receptor. | |||
T22526 |
BML-111
5(S),6(R)-7-trihydroxymethyl Heptanoate |
Others | Others |
inhibits leukotriene B4 (LTB4)-induced polymorphonuclear neutrophils (PMN) chemotaxis | |||
T27916 |
LY 306669
LY-306669,LY306669 |
||
LY 306669 is an antagonist of leukotriene B4 receptor. | |||
T28699 |
SC-41930
CGS 24115,SC41930,CGS24115 |
||
SC-41930 is a potent and selective antagonist of leukotriene B4 receptor. | |||
T28325 |
PD 127443
PD127443,PD-127443 |
||
PD 127443 is a Leukotriene B4 antagonist, it is also a dual inhibitor of cyclooxygenase and 5-lipoxygenase. | |||
T34555 |
SC 45694
SC45694,SC-45694 |
||
SC 45694 is a leukotriene B4 (LTB4) analog. | |||
T27906 |
LY 25648
LY-25648,LY25648 |
||
LY 25648 is an antagonist of leukotriene B4. | |||
T23895 |
WF 11605
WF11605,WF-11605 |
||
WF 11605 is an antagonist of leukotriene B4 produced by a fungus and is a specific antagonist of LTB4. | |||
T25592 |
Labdane F2
|
||
Labdane F2 is an antagonist of thromboxane B2 and leukotriene B4 isolated from the Spanish herb Sideritis javalambrensis. | |||
T68314 |
DG-051
|
||
DG-051 is a novel leukotriene A4 (LTA4H) hydrolase inhibitor of leukotriene B4 biosynthesis. | |||
T68831 |
Furodysinin
|
||
Furodysinin is an agonist of human leukotriene B4 receptor. | |||
T31042 |
CP-195543
UNII-YB1F0V77MK,CP 195543 |
||
CP-195543 is an effective leukotriene B4 antagonist for the treatment of inflammatory diseases. | |||
T15803 |
LY223982
SKF107324,CGS23131 |
Others | Others |
LY223982 is an effective and specific inhibitor of the leukotriene B4 receptor (IC50: 13.2 nM). It also can against [3H]LTB4 binding to LTB4 receptor. | |||
T71221 |
CGS 21595
|
||
CGS 21595 inhibits the formation of 5-hydroxyeicosatetraenoic acid and leukotriene B4; rapidly metabolized to CGS 19213. | |||
T27815 |
Leucettamol A
Leucettamine A |
||
Leucettamol A is a leukotriene B4 receptor antagonist isolated from the marine sponge Leucetta microraphis. It inhibits the formation of a complex composed of the ubiquitin E2 enzyme Ubc13 and Uev1A. | |||
T16395 |
ONO4057
ONO-LB457 |
Leukotriene Receptor | GPCR/G Protein |
ONO4057 是一种具有有效性和口服活性的 Leukotriene B4 受体拮抗剂,其 IC50 值为 0.7±0.3 μM。 ONO4057 对大鼠同种异体移植的免疫抑制作用。 | |||
T10543 |
BIIL-260 hydrochloride
|
Others | Others |
BIIL-260 hydrochloride is a potent and long-acting orally active antagonist of leukotriene B4 (LTB4) receptor with anti-inflammatory activity. It has a high affinity to the LTB4 receptor on isolated human neutrophil cell membranes (Ki: 1.7 nM). | |||
T26958 |
CAY10583
CAY 10583,CAY-10583 |
||
CAY10583 is an agonist of leukotriene B4 receptor type 2 (BLT2). CAY10583 directly promotes keratinocyte migration and indirectly enhances fibroblast proliferation by increasing keratinocyte production of bFGF1 and TGF-β, leadng to accelerate wound closur | |||
T37460 |
Lipoxin B4
Lipoxin B4 |
||
Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes. At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM. | |||
T78678 | LTB4 antagonist 3 | Leukotriene Receptor | GPCR/G Protein |
LTB4 antagonist 3 (compound 24e)为一种具有抗炎活性的LTB4拮抗剂,其IC50为477 nM。 | |||
T27026 |
CJ-13,610
CJ 13610,CJ-13610 |
Lipoxygenase | Metabolism |
CJ-13,610 是一种具有口服活性的非氧化还原型 5-脂氧合酶 (5-LOX) 抑制剂。 CJ-13,610 抑制白三烯 B4 的生物合成并调节巨噬细胞中 IL-6 mRNA 的表达。 | |||
T72625 | LTB4 antagonist 1 | Leukotriene Receptor | GPCR/G Protein |
LTB4 antagonist 1为甲酰胺化合物,高效拮抗白三烯B4 (LTB4),IC50值为288 nM,呈现出明显的抗炎活性。 | |||
T68108 |
Moxilubant
|
LTR | Immunology/Inflammation |
Moxilubant 是一种小分子白三烯B4受体1(LTB4R)拮抗剂,可用于治疗免疫系统疾病、皮肤和肌肉骨骼疾病,可用于研究银屑病和类风湿关节炎。 | |||
T38308 |
Lipoxin B4 methyl ester
|
||
Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4 . LXB4 is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15-HpETE by human leukocytes. At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21504 |
γ-Linolenic Acid methyl ester
Methyl gamma-linolenate,γ-亚麻酸甲酯 |
LTR | Immunology/Inflammation |
γ-Linolenic Acid methyl ester (Methyl gamma-linolenate) 是一种弱白三烯 B4 (LTB4) 受体拮抗剂。 | |||
T19791 |
Chamazulene
BA2784,BA 2784,BA-2784,Dimethulene |
||
Chamazulene is an anti-inflammatory agent as well as an antioxidant-type inhibitor of leukotriene B4 formation. | |||
T37972 |
12-OxoETE
|
||
12-OxoETE is synthesized by human platelets and Aplysia nervous tissue after incubation with arachidonic acid. Microsomal fractions of various tissues will reduce 12-oxoETE to 12(S)-HETE or a mixture of 12(S)- and 12(R)-HETE. 12-OxoETE induces a rapid, dose dependent increase of cytoplasmic free calcium via a leukotriene B4 receptor or a common activation sequence. | |||
T36051 |
Lipoxin A4
脂氧素 A4,LXA4 |
||
Lipoxin A4 (LXA4) is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of (±)15-HETE or 15-HpETE with human leukocytes.[1] LXA4 is equipotent to leukotriene B4 in inducing superoxide generation in human neutrophils at 0.1 μM.2 LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.[2],[3],[4] Analytical and biological comparisons of synth... | |||
TN4584 |
Morolic acid
|
IL Receptor; COX; HIV Protease | Immunology/Inflammation; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Morolic acid and moronic acid have shown sustained antidiabetic and antihyperglycemic action possibly mediated by an insulin sensitization with consequent changes of glucose, cholesterol and triglycerides, in part mediated by inhibition of 11β-HSD 1. Moro |